Aplidin

Overview

By its judgment of 28 October 2020 in case T-594/18, the General Court annulled the Commission Implementing Decision refusing marketing authorisation for Aplidin. As a result, the European Commission has returned the marketing authorisation application for Aplidin to the Agency. EMA is now taking the necessary steps to implement the judgment of the Court.

How useful was this page?

Add your rating
Average
12 ratings
2 ratings
1 rating
1 rating
8 ratings